Idris, Iskandar
University of Nottingham · Royal Derby Hospital · National Institute for Health and Care Research · Nottingham Biomedical Research Centre · University Hospitals of Derby and Burton NHS Foundation Trust
6 papers on CoChatORCID 0000-0002-7548-8288
Most cited papers
- Verified
Early onset type 2 diabetes: risk factors, clinical impact and management
Wilmot, E., & Idris, I. (2014) · Therapeutic Advances in Chronic Disease
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 269
- Verified
Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis
Abdulla, H., Smith, K., Atherton, P. J., & Idris, I. (2016) · Diabetologia
Muscle metabolism and nutritionMetabolism, Diabetes, and Cancer
Cited by 229
- Verified
Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies
Crabtree, T., Ogendo, J.-J., Vinogradova, Y., Gordon, J., & Idris, I. (2022) · Expert Review of Endocrinology & Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 38
- Verified
Effectiveness of a Digital Lifestyle Change Program in Obese and Type 2 Diabetes Populations: Service Evaluation of Real-World Data
Idris, I., Hampton, J., Moncrieff, F., & Whitman, M. (2020) · JMIR Diabetes
Mobile Health and mHealth ApplicationsDiabetes Management and Education
Cited by 25
- Verified
Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists
Crabtree, T. S. J., Adamson, K., Reid, H., Barnes, D., Sivappriyan, S., Bickerton, A., Gallen, I. W., Field, B. C. T., Idris, I., Ryder, R. E. J., et al. (2022) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 14
- Verified
Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery
Wilmington, R., Ardavani, A., Simenacz, A., Green, C., & Idris, I. (2024) · Obesity Surgery
Bariatric Surgery and OutcomesPharmacology and Obesity Treatment
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free